injixo holds approximately 2% of the global WFM market with a meaningfully stronger position in European contact centres where its parent company InVision AG has operated for three decades. That global market share number understates the platform's relevance in the specific segment it serves: mid-market contact centres with 100 to 1,500 seats that need genuine WFM capability at a price point that makes NICE CXone, Genesys Cloud, and Verint inaccessible or difficult to justify. InVision AG was founded in Germany in 1991 and built its first WFM product for the on-premise contact centre market at a time when workforce management software was a niche enterprise category. The company spent more than two decades building WFM methodology into a European market that had different labour law requirements, different collective agreement structures, and different operational norms than the North American market that NICE IEX and Verint were building for simultaneously. That accumulated domain knowledge — 30 years of WFM-specific engineering and customer deployment experience — is the foundation that injixo was built on when InVision launched the cloud-native platform in 2012. The injixo product is not a startup's first attempt at WFM software. It is a mature company's deliberate reinvention of its on-premise product in a cloud-native architecture. The forecasting methodology, the constraint-based scheduling optimization, and the adherence monitoring framework in injixo reflect the same underlying WFM knowledge base as the legacy InVision on-premise product, delivered through a modern cloud architecture with a significantly better user experience. The pricing reality is the most important fact about injixo for North American practitioners evaluating it. injixo operates at a per-agent price point that is substantially below the major enterprise WFM platforms. Published pricing in the range of $8 to $20 per agent per month positions injixo at 5 to 10 times lower cost than NICE CXone or Genesys Cloud for comparable agent counts. That price difference is not driven by lower capability on the core WFM workflow. It is driven by a smaller integration ecosystem, a smaller North American implementation partner network, less brand recognition in the North American enterprise market, and a different go-to-market strategy that relies more on self-service deployment and less on enterprise sales infrastructure. For mid-market contact centres where the WFM budget is constrained and the operation requires genuine forecasting, scheduling, adherence, and intraday management capability, injixo is the most undervalued option in the market. The practitioners who know this are the ones running it. The practitioners who do not know this are the ones paying 8 times more for a brand name. The North American market presence is growing. injixo has been actively expanding its customer base in Canada and the United States since 2019. The integration library for North American ACD platforms — Avaya, Cisco, Genesys Cloud, Amazon Connect, Five9 — has expanded materially in this period. The consultant and implementation partner ecosystem in North America is thinner than in Europe but is developing. For practitioners in Ontario and Texas evaluating injixo, the platform is production-ready for the operation types it is designed for. The implementation support options are less abundant than for NICE or Verint.